封面
市场调查报告书
商品编码
1390559

生物标记技术市场:2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Biomarker Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年,全球生物标记技术市场规模达到354亿美元。展望未来, IMARC Group预计到2028年市场规模将达到759亿美元,2022-2028年复合年增长率(CAGR)为13.56%。

生物标记技术是可靠且经济高效的检测工具,依赖脱氧核糖核酸 (DNA) 和核糖核酸 (RNA) 等遗传生物标记来检测病原体。这些技术广泛应用于不同疾病和病症的早期诊断。它们也用于药物发现和开发过程以及神经系统疾病、心血管疾病、感染、免疫和遗传疾病以及癌症的治疗。一些常用的生物标记技术包括聚合酶链反应(PCR)、下一代定序(NGS)和免疫测定。

生物标记技术市场趋势:

目前,全球患有癌症、心血管、神经和自体免疫疾病的人数大幅增加。再加上对早期有效诊断的需求不断增加,是积极影响市场的关键因素之一。除此之外,老年人口的增加也促进了市场的成长。此外,许多国家的管理机构增加了用于药物发现的研发 (R&D) 资金。再加上医疗基础设施的大幅扩张,尤其是在发展中国家,正在推动市场成长。此外,领先的市场参与者正在引入生物标记技术的众多进步,以提供准确的患者分层。他们也正在开发数位生物标记,帮助使用数位设备收集客观、可量化、生理和行为资料。这些数位生物标记物也与人工智慧 (AI)、机器学习 (ML) 解决方案相结合,用于巨量资料分析和综合决策。其他主要因素,包括人们对早期发现癌症以获得更好治疗的认识不断提高,以及个人收入水平的飙升,预计将推动市场成长。

本报告回答的关键问题:

  • 迄今为止,全球生物标记技术市场表现如何,未来几年将如何表现?
  • COVID-19 对全球生物标记技术市场有何影响?
  • 主要区域市场有哪些?
  • 根据测试类型,市场的细分是什么?
  • 根据指示,市场的细分是什么?
  • 基于产品的市场区隔是什么?
  • 基于技术的市场区隔是什么?
  • 基于应用程式的市场区隔是什么?
  • 产业价值链的各个阶段是什么?
  • 该行业的关键驱动因素和挑战是什么?
  • 全球生物标记技术市场的结构如何?谁是主要参与者?
  • 产业竞争程度如何?

目录

第一章:前言

第 2 章:范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章:执行摘要

第 4 章:简介

  • 概述
  • 主要行业趋势

第 5 章:全球生物标记技术市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章:按测试类型分類的市场

  • 实体切片
    • 市场走向
    • 市场预测
  • 液体活检
    • 市场走向
    • 市场预测

第 7 章:按迹象分類的市场

  • 癌症
    • 市场走向
    • 市场预测
  • 传染性疾病
    • 市场走向
    • 市场预测
  • 自体免疫疾病
    • 市场走向
    • 市场预测
  • 心血管疾病
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章:按产品分類的市场区隔

  • 耗材
    • 市场走向
    • 市场预测
  • 测定
    • 市场走向
    • 市场预测
  • 试剂
    • 市场走向
    • 市场预测
  • 仪器
    • 市场走向
    • 市场预测

第 9 章:依科技分類的市场

  • 聚合酶炼式反应 (PCR)
    • 市场走向
    • 市场预测
  • 次世代定序 (NGS)
    • 市场走向
    • 市场预测
  • 免疫分析
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 10 章:按应用分類的市场细分

  • 药物发现
    • 市场走向
    • 市场预测
  • 临床诊断
    • 市场走向
    • 市场预测
  • 个人化医疗
    • 市场走向
    • 市场预测

第 11 章:按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 12 章:SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章:价值链分析

第 14 章:波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章:价格分析

第16章:竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • LI-COR Inc.
    • Merck KGaA
    • PerkinElmer Inc.
    • QIAGEN NV
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
Product Code: SR112023A4341

Abstract

The global biomarker technologies market size reached US$ 35.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 75.9 Billion by 2028, exhibiting a growth rate (CAGR) of 13.56% during 2022-2028.

Biomarker technologies are reliable and cost-effective detection tools that rely on genetic biomarkers, such as deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), for detecting pathogens. These technologies find extensive application in the early diagnosis of different diseases and disorders. They are also utilized in the drug discovery and development processes and the management of nervous system disorders, cardiovascular diseases, infections, immunological and genetic disorders, and cancer. Some of the commonly used biomarker technologies include polymerase chain reaction (PCR), next-generation sequencing (NGS) and immunoassay.

Biomarker Technologies Market Trends:

There is currently a considerable rise in the number of individuals who are suffering from cancer and cardiovascular, neurological, and autoimmune diseases across the globe. This, coupled with the escalating demand for early and effective diagnosis, represents one of the key factors positively influencing the market. Apart from this, the rising geriatric population is also contributing to the growth of the market. Moreover, there is an increase in research and development (R&D) funding for drug discovery by governing agencies of numerous countries. This, along with the considerably expanding healthcare infrastructure, especially in developing countries, is propelling the market growth. Furthermore, leading market players are introducing numerous advancements in biomarker technologies that provide accurate patient stratification. They are also developing digital biomarkers that aid in collecting objective, quantifiable, physiological, and behavioral data by using digital devices. These digital biomarkers are also incorporated with artificial intelligence (AI), machine learning (ML) solutions for big data analysis, and integrated decision making. Other major factors, including rising awareness about the early detection of cancer for better treatment, and surging income levels of individuals, are projected to impel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global biomarker technologies market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on test type, indication, product, technology and application.

Breakup by Test Type:

Solid Biopsy

Liquid Biopsy

Breakup by Indication:

Cancer

Infectious Diseases

Autoimmune Disorders

Cardiovascular Disorders

Others

Breakup by Product:

Consumables

Assay

Reagent

Instruments

Breakup by Technology:

Polymerase Chain Reaction (PCR)

Next Generation Sequencing (NGS)

Immunoassay

Others

Breakup by Application:

Drug Discovery

Clinical Diagnostics

Personalized Medicine

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., LI-COR Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N.V., Shimadzu Corporation, Thermo Fisher Scientific Inc. and Waters Corporation.

Key Questions Answered in This Report:

  • How has the global biomarker technologies market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global biomarker technologies market?
  • What are the key regional markets?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global biomarker technologies market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biomarker Technologies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Solid Biopsy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Liquid Biopsy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Infectious Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Autoimmune Disorders
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cardiovascular Disorders
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Product

  • 8.1 Consumables
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Assay
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Reagent
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Instruments
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Technology

  • 9.1 Polymerase Chain Reaction (PCR)
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Next Generation Sequencing (NGS)
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Immunoassay
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Drug Discovery
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Clinical Diagnostics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Personalized Medicine
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Agilent Technologies Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Bio-Rad Laboratories Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Danaher Corporation
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 F. Hoffmann-La Roche AG
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
    • 16.3.5 Illumina Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 LI-COR Inc.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Merck KGaA
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 PerkinElmer Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 QIAGEN N.V.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Shimadzu Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Thermo Fisher Scientific Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis
    • 16.3.12 Waters Corporation
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Biomarker Technologies Market: Major Drivers and Challenges
  • Figure 2: Global: Biomarker Technologies Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Biomarker Technologies Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Biomarker Technologies Market: Breakup by Test Type (in %), 2022
  • Figure 5: Global: Biomarker Technologies Market: Breakup by Indication (in %), 2022
  • Figure 6: Global: Biomarker Technologies Market: Breakup by Product (in %), 2022
  • Figure 7: Global: Biomarker Technologies Market: Breakup by Technology (in %), 2022
  • Figure 8: Global: Biomarker Technologies Market: Breakup by Application (in %), 2022
  • Figure 9: Global: Biomarker Technologies Market: Breakup by Region (in %), 2022
  • Figure 10: Global: Biomarker Technologies (Solid Biopsy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Biomarker Technologies (Solid Biopsy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Biomarker Technologies (Liquid Biopsy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Biomarker Technologies (Liquid Biopsy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Biomarker Technologies (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Biomarker Technologies (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Biomarker Technologies (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Biomarker Technologies (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Biomarker Technologies (Autoimmune Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Biomarker Technologies (Autoimmune Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Biomarker Technologies (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Biomarker Technologies (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Biomarker Technologies (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Biomarker Technologies (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Biomarker Technologies (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Biomarker Technologies (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Biomarker Technologies (Assay) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Biomarker Technologies (Assay) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Biomarker Technologies (Reagent) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Biomarker Technologies (Reagent) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Biomarker Technologies (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Biomarker Technologies (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Biomarker Technologies (Polymerase Chain Reaction - PCR) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Biomarker Technologies (Polymerase Chain Reaction - PCR) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Biomarker Technologies (Next Generation Sequencing - NGS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Biomarker Technologies (Next Generation Sequencing - NGS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Biomarker Technologies (Immunoassay) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Biomarker Technologies (Immunoassay) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Biomarker Technologies (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Biomarker Technologies (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Global: Biomarker Technologies (Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Global: Biomarker Technologies (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Global: Biomarker Technologies (Clinical Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Global: Biomarker Technologies (Clinical Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Global: Biomarker Technologies (Personalized Medicine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Global: Biomarker Technologies (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: North America: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: North America: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: United States: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: United States: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Canada: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Canada: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Asia-Pacific: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Asia-Pacific: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: China: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: China: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Japan: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Japan: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: India: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: India: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: South Korea: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: South Korea: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Australia: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Australia: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Indonesia: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Indonesia: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Europe: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Europe: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Germany: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Germany: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: France: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: France: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: United Kingdom: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: United Kingdom: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Italy: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Italy: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Spain: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Spain: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Russia: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Russia: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Others: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Others: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Latin America: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Latin America: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Brazil: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Brazil: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Mexico: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 89: Mexico: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Others: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 91: Others: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 92: Middle East and Africa: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 93: Middle East and Africa: Biomarker Technologies Market: Breakup by Country (in %), 2022
  • Figure 94: Middle East and Africa: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 95: Global: Biomarker Technologies Industry: SWOT Analysis
  • Figure 96: Global: Biomarker Technologies Industry: Value Chain Analysis
  • Figure 97: Global: Biomarker Technologies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biomarker Technologies Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Biomarker Technologies Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 3: Global: Biomarker Technologies Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 4: Global: Biomarker Technologies Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 5: Global: Biomarker Technologies Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 6: Global: Biomarker Technologies Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 7: Global: Biomarker Technologies Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: Biomarker Technologies Market: Competitive Structure
  • Table 9: Global: Biomarker Technologies Market: Key Players